インサイダーの売却・購入履歴
| 自社株取引日 | 役員・従業員名 | 役員・従業員の役職 | 株式の種類 | 売却／購入 | 株数 | 株価 |
|---|---|---|---|---|---|---|
| 2026-02-15 | DUATO, JOAQUIN | Director, CEO and Chairman of the Board | ストックオプション | 購入 | 131,734 | $0.00 |
| 2026-02-15 | DECKER, ROBERT J | VP Corporate Controller | 譲渡制限付株式ユニット | 売却 | 339 | $0.00 |
| 2026-02-15 | DECKER, ROBERT J | VP Corporate Controller | 譲渡制限付株式ユニット | 売却 | 344 | $0.00 |
| 2026-02-15 | DECKER, ROBERT J | VP Corporate Controller | ストックオプション | 購入 | 4,871 | $0.00 |
| 2026-02-15 | DECKER, ROBERT J | VP Corporate Controller | 譲渡制限付株式ユニット | 購入 | 700 | $0.00 |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | 普通株式 | 購入 | 1,349 | $0.00 |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | 普通株式 | 売却 | 385 | $243.45 |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | 普通株式 | 購入 | 1,847 | $0.00 |
| 2026-02-15 | REED, JOHN C | EVP, Innovative Medicine, R&D | 普通株式 | 売却 | 528 | $243.45 |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | 譲渡制限付株式ユニット | 売却 | 606 | $0.00 |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | 譲渡制限付株式ユニット | 売却 | 635 | $0.00 |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | ストックオプション | 購入 | 16,945 | $0.00 |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | 普通株式 | 売却 | 325 | $243.45 |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | 普通株式 | 購入 | 635 | $0.00 |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | 普通株式 | 売却 | 310 | $243.45 |
| 2026-02-15 | WENGEL, KATHRYN E | EVP, Chief TO and Risk Officer | 普通株式 | 購入 | 606 | $0.00 |
| 2026-02-13 | SCHMID, TIMOTHY | EVP, WW Chair, MedTech | 普通株式 | 売却 | 8 | $244.55 |
| 2026-02-13 | BROADHURST, VANESSA | EVP, Global Corp Affairs | 譲渡制限付株式ユニット | 売却 | 408 | $0.00 |